$179.60
2.71.53%
Last update: 1:19 PM
15 minutes delayed
Comments
Loading...
NICE
NICENASDAQ
Unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
NICE (NASDAQ:NICE) Stock, Analyst Ratings, Price Targets, Forecasts
NICE Ltd has a consensus price target of $269.31 based on the ratings of 17 analysts. The high is $346 issued by Citigroup on June 12, 2024. The low is $213 issued by Piper Sandler on July 10, 2024. The 3 most-recent analyst ratings were released by Piper Sandler, Morgan Stanley, and Northland Capital Markets on July 10, 2024, June 14, 2024, and June 13, 2024, respectively. With an average price target of $252.67 between Piper Sandler, Morgan Stanley, and Northland Capital Markets, there's an implied 37.15% upside for NICE Ltd from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Piper Sandler
Morgan Stanley
Northland Capital Markets
Citigroup
JMP Securities
1calculated from analyst ratings
Analyst Ratings for NICE
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 07/10/2024 | Buy Now | 15.62% | Piper Sandler | James Fish | $238 → $213 | Maintains | Overweight | Get Alert |
| 06/14/2024 | Buy Now | 30.27% | Morgan Stanley | Hamza Fodderwala | $290 → $240 | Maintains | Overweight | Get Alert |
| 06/13/2024 | Buy Now | 65.55% | Northland Capital Markets | Michael Latimore | $305 → $305 | Maintains | Outperform | Get Alert |
| 06/12/2024 | Buy Now | 87.81% | Citigroup | Tyler Radke | $339 → $346 | Maintains | Buy | Get Alert |
| 06/12/2024 | Buy Now | 62.84% | JMP Securities | Patrick Walravens | $300 → $300 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 06/12/2024 | Buy Now | 24.84% | RBC Capital | Rishi Jaluria | $265 → $230 | Maintains | Outperform | Get Alert |
| 06/12/2024 | Buy Now | 35.7% | Wedbush | Daniel Ives | → $250 | Reiterates | Outperform → Outperform | Get Alert |
| 06/12/2024 | Buy Now | 62.84% | DA Davidson | Gil Luria | $300 → $300 | Maintains | Buy | Get Alert |
| 06/12/2024 | Buy Now | 22.13% | Rosenblatt | Catharine Trebnick | $285 → $225 | Maintains | Buy | Get Alert |
| 05/17/2024 | Buy Now | 43.84% | RBC Capital | Rishi Jaluria | $285 → $265 | Maintains | Outperform | Get Alert |
| 05/17/2024 | Buy Now | 24.84% | Jefferies | Samad Samana | $280 → $230 | Maintains | Buy | Get Alert |
| 05/17/2024 | Buy Now | 62.84% | JMP Securities | Patrick Walravens | $343 → $300 | Maintains | Market Outperform | Get Alert |
| 05/17/2024 | Buy Now | 51.98% | Mizuho | Siti Panigrahi | $300 → $280 | Maintains | Buy | Get Alert |
| 05/17/2024 | Buy Now | 46.56% | B of A Securities | Michael Funk | $300 → $270 | Maintains | Buy | Get Alert |
| 05/15/2024 | Buy Now | 86.18% | JMP Securities | Patrick Walravens | → $343 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 04/23/2024 | Buy Now | 54.7% | Rosenblatt | Catharine Trebnick | → $285 | Initiates | → Buy | Get Alert |
| 03/13/2024 | Buy Now | 62.84% | DA Davidson | Gil Luria | $250 → $300 | Upgrade | Neutral → Buy | Get Alert |
| 03/12/2024 | Buy Now | 62.84% | DA Davidson | Gil Luria | $250 → $300 | Upgrade | Neutral → Buy | Get Alert |
| 02/23/2024 | Buy Now | 86.18% | JMP Securities | Patrick Walravens | — | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 02/23/2024 | Buy Now | 81.84% | Citigroup | Tyler Radke | $334 → $335 | Maintains | Buy | Get Alert |
| 02/23/2024 | Buy Now | 54.7% | RBC Capital | Rishi Jaluria | $238 → $285 | Maintains | Outperform | Get Alert |
| 02/23/2024 | Buy Now | 62.84% | Mizuho | Siti Panigrahi | $244 → $300 | Maintains | Buy | Get Alert |
| 02/23/2024 | Buy Now | 73.7% | Barclays | Tavy Rosner | $283 → $320 | Maintains | Overweight | Get Alert |
| 02/23/2024 | Buy Now | 46.56% | Wedbush | Daniel Ives | $230 → $270 | Maintains | Outperform | Get Alert |
| 02/23/2024 | Buy Now | 62.84% | Oppenheimer | Timothy Horan | $225 → $300 | Maintains | Outperform | Get Alert |
| 02/21/2024 | Buy Now | 81.3% | Citigroup | Tyler Radke | $283 → $334 | Maintains | Buy | Get Alert |
| 02/01/2024 | Buy Now | 86.18% | JMP Securities | Patrick Walravens | → $343 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 01/30/2024 | Buy Now | 62.84% | Northland Capital Markets | Michael Latimore | → $300 | Initiates | → Outperform | Get Alert |
| 01/22/2024 | Buy Now | 86.18% | JMP Securities | Patrick Walravens | → $343 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 12/18/2023 | Buy Now | 86.18% | JMP Securities | Patrick Walravens | → $343 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 11/22/2023 | Buy Now | 29.19% | RBC Capital | Rishi Jaluria | → $238 | Reiterates | Outperform → Outperform | Get Alert |
| 11/17/2023 | Buy Now | 29.19% | RBC Capital | Rishi Jaluria | → $238 | Reiterates | Outperform → Outperform | Get Alert |
| 10/16/2023 | Buy Now | 19.42% | Morgan Stanley | Hamza Fodderwala | $225 → $220 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 10/09/2023 | Buy Now | 86.18% | JMP Securities | Patrick Walravens | → $343 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 10/05/2023 | Buy Now | 29.19% | RBC Capital | Rishi Jaluria | → $238 | Reiterates | Outperform → Outperform | Get Alert |
| 10/05/2023 | Buy Now | 22.13% | Oppenheimer | Timothy Horan | $250 → $225 | Maintains | Outperform | Get Alert |
| 09/29/2023 | Buy Now | 3.13% | DA Davidson | Gil Luria | → $190 | Initiates | → Neutral | Get Alert |
| 08/18/2023 | Buy Now | 29.19% | RBC Capital | Rishi Jaluria | → $238 | Reiterates | Outperform → Outperform | Get Alert |
| 08/18/2023 | Buy Now | 86.18% | JMP Securities | Patrick Walravens | → $343 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 08/15/2023 | Buy Now | 83.47% | Citigroup | Tyler Radke | $278 → $338 | Maintains | Buy | Get Alert |
| 07/26/2023 | Buy Now | — | William Blair | Matt Stotler | — | Initiates | → Outperform | Get Alert |
| 06/14/2023 | Buy Now | 86.18% | JMP Securities | Patrick Walravens | → $343 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 06/07/2023 | Buy Now | 29.19% | RBC Capital | Rishi Jaluria | → $238 | Reiterates | Outperform → Outperform | Get Alert |
| 05/31/2023 | Buy Now | 32.44% | Mizuho | Siti Panigrahi | → $244 | Initiates | → Buy | Get Alert |
| 05/12/2023 | Buy Now | 24.84% | Wedbush | Daniel Ives | $250 → $230 | Maintains | Outperform | Get Alert |
| 05/12/2023 | Buy Now | 27.56% | Jefferies | Samad Samana | $260 → $235 | Maintains | Buy | Get Alert |
| 05/10/2023 | Buy Now | 50.9% | Citigroup | Tyler Radke | $277 → $278 | Maintains | Buy | Get Alert |
| 02/24/2023 | Buy Now | 50.36% | Citigroup | Tyler Radke | $301 → $277 | Maintains | Buy | Get Alert |
| 01/17/2023 | Buy Now | 23.22% | Piper Sandler | James Fish | $222 → $227 | Upgrade | Neutral → Overweight | Get Alert |
| 11/11/2022 | Buy Now | 22.13% | Morgan Stanley | Meta Marshall | $215 → $225 | Maintains | Equal-Weight | Get Alert |
| 11/11/2022 | Buy Now | 41.13% | Citigroup | Tyler Radke | $254 → $260 | Maintains | Buy | Get Alert |
| 11/01/2022 | Buy Now | 37.87% | Citigroup | Tyler Radke | $275 → $254 | Maintains | Buy | Get Alert |
| 10/11/2022 | Buy Now | 16.7% | Morgan Stanley | Meta Marshall | $235 → $215 | Maintains | Equal-Weight | Get Alert |
| 08/25/2022 | Buy Now | 28.1% | Piper Sandler | James Fish | → $236 | Initiates | → Neutral | Get Alert |
| 08/22/2022 | Buy Now | 35.7% | Wedbush | Daniel Ives | $220 → $250 | Maintains | Outperform | Get Alert |
| 08/19/2022 | Buy Now | 49.27% | JP Morgan | Paul Chung | $260 → $275 | Maintains | Overweight | Get Alert |
| 08/19/2022 | Buy Now | 43.84% | RBC Capital | Rishi Jaluria | $240 → $265 | Maintains | Outperform | Get Alert |
| 07/26/2022 | Buy Now | 53.61% | Barclays | Tavy Rosner | $356 → $283 | Maintains | Overweight | Get Alert |
| 07/14/2022 | Buy Now | 27.56% | Morgan Stanley | Meta Marshall | $260 → $235 | Maintains | Equal-Weight | Get Alert |
| 05/13/2022 | Buy Now | 30.27% | RBC Capital | Rishi Jaluria | $365 → $240 | Maintains | Outperform | Get Alert |
| 02/22/2022 | Buy Now | 41.13% | Morgan Stanley | Meta Marshall | $315 → $260 | Maintains | Equal-Weight | Get Alert |
| 02/18/2022 | Buy Now | 73.7% | Jefferies | Samad Samana | $350 → $320 | Maintains | Buy | Get Alert |
| 12/16/2021 | Buy Now | 70.98% | Morgan Stanley | Meta Marshall | — | Downgrade | Overweight → Equal-Weight | Get Alert |
| 09/09/2021 | Buy Now | 86.18% | JMP Securities | Patrick Walravens | — | Maintains | Market Outperform | Get Alert |
| 08/06/2021 | Buy Now | 76.41% | RBC Capital | Rishi Jaluria | — | Maintains | Outperform | Get Alert |
FAQ
What is the target price for NICE (NICE) stock?
The latest price target for NICE (NASDAQ:NICE) was reported by Piper Sandler on July 10, 2024. The analyst firm set a price target for $213.00 expecting NICE to rise to within 12 months (a possible 18.60% upside). 41 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for NICE (NICE)?
The latest analyst rating for NICE (NASDAQ:NICE) was provided by Piper Sandler, and NICE maintained their overweight rating.
When was the last upgrade for NICE (NICE)?
The last upgrade for NICE Ltd happened on March 13, 2024 when DA Davidson raised their price target to $300. DA Davidson previously had a neutral for NICE Ltd.
When was the last downgrade for NICE (NICE)?
The last downgrade for NICE Ltd happened on December 16, 2021 when Morgan Stanley changed their price target from N/A to $315 for NICE Ltd.
When is the next analyst rating going to be posted or updated for NICE (NICE)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of NICE, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for NICE was filed on July 10, 2024 so you should expect the next rating to be made available sometime around July 10, 2025.
Is the Analyst Rating NICE (NICE) correct?
While ratings are subjective and will change, the latest NICE (NICE) rating was a maintained with a price target of $238.00 to $213.00. The current price NICE (NICE) is trading at is $179.60, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.